Effect of population aging on proportionate mortality from heart disease and cancer, U.S. 2000-2050
- PMID: 15746026
- DOI: 10.1093/geronb/60.2.s110
Effect of population aging on proportionate mortality from heart disease and cancer, U.S. 2000-2050
Abstract
Objective: One-fourth of all deaths in the United States occur after age 85 (646,900 of 2,392,619 total deaths in 1999). By 2050 (assuming 1999 age-specific death rates), 47.4% of all deaths will occur after age 85 (2,994,935 of 6,314,725 total deaths). As we age, heart disease becomes increasingly important relative to cancer as a cause of death. Thus, as age at death is postponed, future populations will be dying of different age-specific causes. The study objective was to project the effect of population aging on future proportionate mortality rates for heart disease and cancer.
Methods: Using Census Bureau population projections and assuming 1999 age-specific death rates, the authors calculated the number of deaths from heart disease, cancer, and all causes in 10-year intervals from 2000 to 2050.
Result: During this period, the total number of deaths for heart disease and cancer will increase 2.8-fold and 2.3-fold, respectively. The proportionate mortality rate for heart disease will increase from 30% to 33%, and the rate for cancer will drop from 23% to 20%.
Discussion: Changes in age distribution between now and 2050 will cause heart disease to increase its dominance over all other causes of death, and proportionate mortality for cancer will decline.
Similar articles
-
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.MMWR Suppl. 2014 Oct 31;63(4):3-27. MMWR Suppl. 2014. PMID: 25356673
-
The effect of revised populations on mortality statistics for the United States, 2000.Natl Vital Stat Rep. 2003 Jun 5;51(9):1-24. Natl Vital Stat Rep. 2003. PMID: 12795490
-
Deaths: preliminary data for 2002.Natl Vital Stat Rep. 2004 Feb 11;52(13):1-47. Natl Vital Stat Rep. 2004. PMID: 14998175
-
Projecting the impact of AIDS on mortality.AIDS. 1998;12 Suppl 1:S29-39. AIDS. 1998. PMID: 9677187 Review.
-
Disease and injury in California with projections to the year 2007. Implications for medical education.West J Med. 1998 May;168(5):378-99. West J Med. 1998. PMID: 9614796 Free PMC article. Review.
Cited by
-
Epidemiology of resistant hypertension.J Clin Hypertens (Greenwich). 2011 Jul;13(7):523-8. doi: 10.1111/j.1751-7176.2011.00445.x. Epub 2011 Mar 28. J Clin Hypertens (Greenwich). 2011. PMID: 21762366 Free PMC article. Review.
-
Mid-aged and aged wild-type and progestin receptor knockout (PRKO) mice demonstrate rapid progesterone and 3alpha,5alpha-THP-facilitated lordosis.Psychopharmacology (Berl). 2006 May;185(4):423-32. doi: 10.1007/s00213-005-0300-4. Epub 2006 Mar 17. Psychopharmacology (Berl). 2006. PMID: 16544163
-
Rapamycin extends life- and health span because it slows aging.Aging (Albany NY). 2013 Aug;5(8):592-8. doi: 10.18632/aging.100591. Aging (Albany NY). 2013. PMID: 23934728 Free PMC article.
-
State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension.J Clin Hypertens (Greenwich). 2008 Feb;10(2):130-9. doi: 10.1111/j.1751-7176.2008.07309.x. J Clin Hypertens (Greenwich). 2008. PMID: 18256578 Free PMC article. Review.
-
Desirable therapeutic characteristics of an optimal antihypertensive agent.Drugs. 2006;66(9):1239-52. doi: 10.2165/00003495-200666090-00006. Drugs. 2006. PMID: 16827600 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials